Novel genes related to ceftriaxone resistance found among ceftriaxone-resistant Neisseria gonorrhoeae strains selected in vitro

Antimicrobial Agents and Chemotherapy

Volumn 60, Issue 4, 2016, Pages 2043-2051

  Gong, Zijian ^a   Lai, Wei ^a   Liu, Min ^b   Hua, Zhengshuang ^a   Sun, Yayin ^a   Xu, Qingfang ^a   Xia, Yue ^a   Zhao, Yue ^a   Xie, Xiaoyuan ^a  

^a SUN YAT SEN UNIVERSITY   (China)

^b DERMATOLOGY HOSPITAL OF SOUTHERN MEDICAL UNIVERSITY   (China)

Author keywords

[No Author keywords available]

Indexed keywords

ABC TRANSPORTER; ABC TRANSPORTER FARB; ABC TRANSPORTER HFQ; ABC TRANSPORTER TFQ; BACTERIAL PROTEIN; CEFTRIAXONE; CEFUROXIME; CIPROFLOXACIN; EXBB PROTEIN; PENICILLIN DERIVATIVE; PILM PROTEIN; PILN PROTEIN; PILQ PROTEIN; SPECTINOMYCIN; TETRACYCLINE; TRANSCRIPTOME; UNCLASSIFIED DRUG; ANTIINFECTIVE AGENT; PENICILLIN G;

ANTIBIOTIC RESISTANCE; ARTICLE; BACTERIAL GENE; BACTERIAL GENOME; BACTERIAL STRAIN; CONTROLLED STUDY; CROSS RESISTANCE; DOWN REGULATION; GENE MUTATION; GENE OVEREXPRESSION; IN VITRO STUDY; METABOLIC RATE; MINIMUM INHIBITORY CONCENTRATION; NEISSERIA GONORRHOEAE; NONHUMAN; PHARMACOGENETICS; PRIORITY JOURNAL; PROMOTER REGION; UPREGULATION; AMINO ACID SEQUENCE; DRUG EFFECTS; GENE EXPRESSION REGULATION; GENETIC TRANSFORMATION; GENETICS; GONORRHEA; HUMAN; ISOLATION AND PURIFICATION; METABOLISM; MICROBIAL SENSITIVITY TEST; MICROBIOLOGY; MULTIDRUG RESISTANCE; MUTATION; SEQUENCE ALIGNMENT;

AMINO ACID SEQUENCE; ANTI-BACTERIAL AGENTS; ATP-BINDING CASSETTE TRANSPORTERS; CEFTRIAXONE; CEFUROXIME; DRUG RESISTANCE, MULTIPLE, BACTERIAL; GENE EXPRESSION REGULATION, BACTERIAL; GENES, BACTERIAL; GONORRHEA; HUMANS; MICROBIAL SENSITIVITY TESTS; MUTATION; NEISSERIA GONORRHOEAE; PENICILLIN G; SEQUENCE ALIGNMENT; TRANSCRIPTOME; TRANSFORMATION, GENETIC;

EID: 84963512404     PISSN: 00664804     EISSN: 10986596     Source Type: Journal    
DOI: 10.1128/AAC.00149-15     Document Type: Article

References (54)

1. James WD, Elston DM, Berger TG, Andrews GC. 2011. Andrews' diseases of the skin: clinical dermatology. Saunders, London, United Kingdom.
2. Torjesen I. 2012. Experts call for more safe sex education as gonorrhoea cases rise by a quarter in England. BMJ 344:e3870. http://dx.doi.org/10.1136/bmj.e3870.
3. Jakopanec I, Borgen K, Aavitsland P. 2009. The epidemiology of gonorrhoea in Norway, 1993-2007: past victories, future challenges. BMC Infect Dis 9:33. http://dx.doi.org/10.1186/1471-2334-9-33.
4. Velicko I, Unemo M. 2009. Increase in reported gonorrhoea cases in Sweden, 2001-2008. Euro Surveill 14(34): pii= 19315. http://www.eurosurveillance.org/ViewArticle.aspx?ArticleId = 19315.
5. Linhart Y, Shohat T, Amitai Z, Gefen D, Srugo I, Blumstein G, Dan M. 2008. Sexually transmitted infections among brothel-based sex workers in Tel-Aviv area, Israel: high prevalence of pharyngeal gonorrhoea. Int J STD AIDS 19:656-659. http://dx.doi.org/10.1258/ijsa.2008.008127.
6. Communicable Diseases Intelligence Quarterly Report. 2001. Annual report of the Australian Gonococcal Surveillance Programme, 2000. Commun Dis Intell Q Rep 25:59-63.
7. Australian Gonococcal Surveillance Programme. 2011. Australian Gonococcal Surveillance Programme annual report, 2010. Commun Dis Intell Q Rep 35:229-236.
8. Bala M, Ray K, Gupta SM, Muralidhar S, Jain RK. 2007. Changing trends of antimicrobial susceptibility patterns of Neisseria gonorrhoeae in India and the emergence of ceftriaxone less susceptible N.gonorrhoeae strains. J Antimicrob Chemother 60:582-586. http://dx.doi.org/10.1093/jac/dkm238.
9. Su X, Jiang F, Qimuge, Dai X, Sun H, Ye S. 2007. Surveillance of antimicrobial susceptibilities in Neisseria gonorrhoeae in Nanjing, China, 1999-2006. SexTransm Dis 34:995-999.
10. Martin IM, Hoffmann S, Ison CA. 2006. European Surveillance of Sexually Transmitted Infections (ESSTI): the first combined antimicrobial susceptibility data for Neisseria gonorrhoeae in Western Europe. J Antimicrob Chemother 58:587-593. http://dx.doi.org/10.1093/jac/dkl265.
11. Workowski KA, Berman SM, Douglas JJ. 2008. Emerging antimicrobial resistance in Neisseria gonorrhoeae: urgent need to strengthen prevention strategies. Ann Intern Med 148:606-613. http://dx.doi.org/10.7326/0003-4819-148-8-200804150-00005.
12. WHO Western Pacific Programme, South East Asian Gonococcal Antimicrobial Surveillance Programme, Tapsall JW, Limnios EA, Abu Bakar HM, Darussalam B, Ping YY, Buadromo EM, Kumar P, Singh S, Lo J, Bala M, Risbud A, Deguchi T, Tanaka M, Watanabe Y, Lee K, Chong Y, Noikaseumsy S, Phouthavane T, Sam IC, Tundev O, Lwin KM, Eh PH, Goarant C, Goursaud R, Bathgate T, Brokenshire M, Latorre L, Velemu E, Carlos C, Leano S, Telan EO, Goh SS, Koh ST, Ngan C, Tan AL, Mananwatte S, Piyanoot N, Lokpichat S, Sirivongranson P, Fakahau M, Sitanilei H, Hung LV. 2010. Surveillance of antibiotic resistance in Neisseria gonorrhoeae in the WHO Western Pacific and South East Asian regions, 2007-2008. Commun Dis Intell Q Rep 34:1-7.
13. CDC. 2012. Update to CDC's sexually transmitted diseases treatment guidelines, 2010: oral cephalosporins no longer a recommended treatment for gonococcal infections. MMWR Morb Mortal Wkly Rep 61:590-594.
14. Public Health Agency of Canada. 2013. Canadian guidelines on sexually transmitted infections. Public Health Agency of Canada, Toronto, Ontario, Canada. http://www.phac-aspc.gc.ca/std-mts/sti-its/cgsti-ldcits/section-5-6-eng.phpoc361210470. Accessed 11 June 2015.
15. Camara J, Serra J, Ayats J, Bastida T, Carnicer-Pont D, Andreu A, Ardanuy C. 2012. Molecular characterization of two high-level ceftriaxone-resistant Neisseria gonorrhoeae isolates detected in Catalonia, Spain. J Antimicrob Chemother 67:1858-1860. http://dx.doi.org/10.1093/jac/dks162.
16. Carnicer-Pont D, Smithson A, Fina-Homar E, Bastida MT. 2012. First cases of Neisseria gonorrhoeae resistant toceftriaxonein Catalonia, Spain, May 2011. Enferm Infecc Microbiol Clin 30:218-219. http://dx.doi.org/10.1016/j.eimc.2011.11.010.
17. Ohnishi M, Golparian D, Shimuta K, Saika T, Hoshina S, Iwasaku K, Nakayama S, Kitawaki J, Unemo M. 2011. Is Neisseria gonorrhoeae initiating a future era of untreatable gonorrhea? Detailed characterization of the first strain with high-level resistance to ceftriaxone. Antimicrob Agents Chemother 55:3538-3545. http://dx.doi.org/10.1128/AAC.00325-11.
18. Unemo M, Golparian D, Nicholas R, Ohnishi M, Gallay A, Sednaoui P. 2012. High-level cefixime-and ceftriaxone-resistant Neisseria gonorrhoeae in France: novel penA mosaic allele in a successful international clone causes treatment failure. Antimicrob Agents Chemother 56:1273-1280. http://dx.doi.org/10.1128/AAC.05760-11.
19. Lindberg R, Fredlund H, Nicholas R, Unemo M. 2007. Neisseria gonorrhoeae isolates with reduced susceptibility to cefixime and ceftriaxone: association with genetic polymorphisms inpenA, mtrR, porB1b, andponA. Antimicrob Agents Chemother 51:2117-2122. http://dx.doi.org/10.1128/AAC.01604-06.
20. Tanaka M, Nakayama H, Huruya K, Konomi I, Irie S, Kanayama A, Saika T, Kobayashi I. 2006. Analysis of mutations within multiple genes associated with resistance in a clinical isolate of Neisseria gonorrhoeae with reduced ceftriaxone susceptibility that shows a multidrug-resistant phenotype. Int J Antimicrob Agents 27:20-26. http://dx.doi.org/10.1016/j.ijantimicag.2005.08.021.
21. Zhao S, Duncan M, Tomberg J, Davies C, Unemo M, Nicholas RA. 2009. Genetics of chromosomally mediated intermediate resistance to ceftriaxone and cefixime in Neisseria gonorrhoeae. Antimicrob Agents Chemother 53:3744-3751. http://dx.doi.org/10.1128/AAC.00304-09.
22. Ropp PA, Hu M, Olesky M, Nicholas RA. 2002. Mutations in ponA, the gene encoding penicillin-binding protein 1, and a novel locus, penC, are required for high-level chromosomally mediated penicillin resistance in Neisseria gonorrhoeae. Antimicrob Agents Chemother 46:769-777. http://dx.doi.org/10.1128/AAC.46.3.769-777.2002.
23. Zhao S, Tobiason DM, Hu M, Seifert HS, Nicholas RA. 2005. The penC mutation conferring antibiotic resistance in Neisseria gonorrhoeae arises from a mutation in the PilQ secretin that interferes with multimer stability. Mol Microbiol 57:1238-1251. http://dx.doi.org/10.1111/j.1365-2958.2005.04752.x.
24. Ameyama S, Onodera S, Takahata M, Minami S, Maki N, Endo K, Goto H, Suzuki H, Oishi Y. 2002. Mosaic-like structure of penicillin-binding protein 2 gene (penA) in clinical isolates of Neisseria gonorrhoeae with reduced susceptibility to cefixime. Antimicrob Agents Chemother 46:3744-3749. http://dx.doi.org/10.1128/AAC.46.12.3744-3749.2002.
25. Liao M, Gu WM, Yang Y, Dillon JA. 2011. Analysis of mutations in multiple loci of Neisseria gonorrhoeae isolates reveals effects of PIB, PBP2 and MtrR on reduced susceptibility to ceftriaxone. J Antimicrob Chemother 66:1016-1023. http://dx.doi.org/10.1093/jac/dkr021.
26. Whiley DM, Jacobsson S, Tapsall JW, Nissen MD, Sloots TP, Unemo M. 2010. Alterations of the pilQ gene in Neisseria gonorrhoeae are unlikely contributors to decreased susceptibility to ceftriaxone and cefixime in clinical gonococcal strains. J Antimicrob Chemother 65:2543-2547. http://dx.doi.org/10.1093/jac/dkq377.
27. Thakur SD, Starnino S, Horsman GB, Levett PN, Dillon JR. 2014. Unique combinedpenA/mtrR/porBmutations and NG-MAST strain types associated with ceftriaxone and cefixime MIC increases in a 'susceptible' Neisseria gonorrhoeae population. J Antimicrob Chemother 69:1510-1516. http://dx.doi.org/10.1093/jac/dkt543.
28. Whiley DM, Goire N, Lambert SB, Ray S, Limnios EA, Nissen MD, Sloots TP, Tapsall JW. 2010. Reduced susceptibility to ceftriaxone in Neisseria gonorrhoeae is associated with mutations G542S, P551S and P551L in the gonococcal penicillin-binding protein 2. J Antimicrob Chemother 65:1615-1618. http://dx.doi.org/10.1093/jac/dkq187.
29. Unemo M, Fasth O, Fredlund H, Limnios A, Tapsall J. 2009. Phenotypic and genetic characterization of the 2008 WHO Neisseria gonorrhoeae reference strain panel intended for global quality assurance and quality control of gonococcal antimicrobial resistance surveillance for public health purposes. J Antimicrob Chemother 63:1142-1151. http://dx.doi.org/10.1093/jac/dkp098.
30. Ye S, Su X, Wang Q, Yin Y, Dai X, Sun H. 2002. Surveillance of antibiotic resistance of Neisseria gonorrhoeae isolates in China, 1993-1998. Sex Transm Dis 29:242-245. http://dx.doi.org/10.1097/00007435-200204000-00010.
31. Clinical and Laboratory Standards Institute. 2009. Performance standards for antimicrobial susceptibility testing, 19th informational supplement. CLSI document M100-S19. CLSI, Wayne, PA.
32. Kuroda H, Kuroda M, Cui L, Hiramatsu K. 2007. Subinhibitory concentrations of beta-lactam induce haemolytic activity in Staphylococcus aureus through the SaeRS two-component system. FEMS Microbiol Lett 268:98-105. http://dx.doi.org/10.1111/j.1574-6968.2006.00568.x.
33. Tattevin P, Basuino L, Chambers HF. 2009. Subinhibitory fluoroquinolone exposure selects for reduced beta-lactam susceptibility in methicillin-resistant Staphylococcus aureus and alterations in the SOS-mediated response. Res Microbiol 160:187-192. http://dx.doi.org/10.1016/j.resmic.2009.03.003.
34. Goh EB, Yim G, Tsui W, McClure J, Surette MG, Davies J. 2002. Transcriptional modulation of bacterial gene expression by subinhibitory concentrations of antibiotics. Proc Natl Acad Sci U S A 99:17025-17030. http://dx.doi.org/10.1073/pnas.252607699.
35. Lindback E, Rahman M, Jalal S, Wretlind B. 2002. Mutations in gyrA, gyrB, parC, and parE in quinolone-resistant strains of Neisseria gonorrhoeae. APMIS 110:651-657. http://dx.doi.org/10.1034/j.1600-0463.2002.1100909.x.
36. Ohnishi M, Watanabe Y, Ono E, Takahashi C, Oya H, Kuroki T, Shimuta K, Okazaki N, Nakayama S, Watanabe H. 2010. Spread of a chromosomal cefixime-resistant penA gene among different Neisseria gonorrhoeae lineages. Antimicrob Agents Chemother 54:1060-1067. http://dx.doi.org/10.1128/AAC.01010-09.
37. Whiley DM, Limnios EA, Ray S, Sloots TP, Tapsall JW. 2007. Diversity of penA alterations and subtypes in Neisseria gonorrhoeae strains from Sydney, Australia, that are less susceptible to ceftriaxone. Antimicrob Agents Chemother 51:3111-3116. http://dx.doi.org/10.1128/AAC.00306-07.
38. Ito M, Deguchi T, Mizutani KS, Yasuda M, Yokoi S, Ito S, Takahashi Y, Ishihara S, Kawamura Y, Ezaki T. 2005. Emergence and spread of Neisseria gonorrhoeae clinical isolates harboring mosaic-like structure of penicillin-binding protein 2 in central Japan. Antimicrob Agents Chemother 49:137-143. http://dx.doi.org/10.1128/AAC.49.1.137-143.2005.
39. Osaka K, Takakura T, Narukawa K, Takahata M, Endo K, Kiyota H, Onodera S. 2008. Analysis of amino acid sequences of penicillin-binding protein 2 in clinical isolates of Neisseria gonorrhoeae with reduced susceptibility to cefixime and ceftriaxone. J Infect Chemother 14:195-203. http://dx.doi.org/10.1007/s10156-008-0610-7.
40. Takahata S, Senju N, Osaki Y, Yoshida T, Ida T. 2006. Amino acid substitutions in mosaic penicillin-binding protein 2 associated with reduced susceptibility to cefixime in clinical isolates of Neisseria gonorrhoeae. Antimicrob Agents Chemother 50:3638-3645. http://dx.doi.org/10.1128/AAC.00626-06.
41. Tapsall JW, Ray S, Limnios A. 2010. Characteristics and population dynamicsof mosaic penA allele-containing Neisseria gonorrhoeae isolates collected in Sydney, Australia, in 2007-2008. Antimicrob Agents Chemother 54:554-556. http://dx.doi.org/10.1128/AAC.01108-09.
42. Wendlandt S, Lozano C, Kadlec K, Gomez-Sanz E, Zarazaga M, Torres C, Schwarz S. 2013. The enterococcal ABC transporter gene lsa (E) confers combined resistance to lincosamides, pleuromutilins and streptogramin A antibiotics in methicillin-susceptible and methicillin-resistant Staphylococcus aureus. J Antimicrob Chemother 68:473-475. http://dx.doi.org/10.1093/jac/dks398.
43. Warburton PJ, Ciric L, Lerner A, Seville LA, Roberts AP, Mullany P, Allan E. 2013. TetAB (46), a predicted heterodimeric ABC transporter conferring tetracycline resistance in Streptococcus australis isolated from the oral cavity. J Antimicrob Chemother 68:17-22. http://dx.doi.org/10.1093/jac/dks351.
44. Dintner S, Staron A, Berchtold E, Petri T, Mascher T, Gebhard S. 2011. Coevolution of ABC transporters and two-component regulatory systems as resistance modules against antimicrobial peptides in Firmicutes bacteria. J Bacteriol 193:3851-3862. http://dx.doi.org/10.1128/JB.05175-11.
45. Soualhine H, Brochu V, Menard F, Papadopoulou B, Weiss K, Bergeron MG, Legare D, Drummelsmith J, Ouellette M. 2005. A proteomic analysis of penicillin resistance in Streptococcus pneumoniae reveals a novel role for PstS, a subunit of the phosphate ABC transporter. Mol Microbiol 58:1430-1440. http://dx.doi.org/10.1111/j.1365-2958.2005.04914.x.
46. Lee EH, Shafer WM. 1999. The farAB-encoded efflux pump mediates resistance of gonococci to long-chained antibacterial fatty acids. Mol Microbiol 33:839-845.
47. Yamada J, Yamasaki S, Hirakawa H, Hayashi-Nishino M, Yamaguchi A, Nishino K. 2010. Impact of the RNA chaperone Hfq on multidrug resistance in Escherichia coli. J Antimicrob Chemother 65:853-858. http://dx.doi.org/10.1093/jac/dkq067.
48. Hayashi-Nishino M, Fukushima A, Nishino K. 2012. Impact of hfq on the intrinsic drug resistanceof Salmonella enterica serovar Typhimurium. Front Microbiol 3:205. http://dx.doi.org/10.3389/fmicb.2012.00205.
49. Rouquette-Loughlin C, Stojiljkovic I, Hrobowski T, Balthazar JT, Shafer WM. 2002. Inducible, but not constitutive, resistance of gonococci to hydrophobic agents due to the MtrC-MtrD-MtrE efflux pump requires TonB-ExbB-ExbD proteins. Antimicrob Agents Chemother 46:561-565. http://dx.doi.org/10.1128/AAC.46.2.561-565.2002.
50. Trindade MB, Job V, Contreras-Martel C, Pelicic V, Dessen A. 2008. Structure of a widely conserved type IV pilus biogenesis factor that affects the stability of secretin multimers. J Mol Biol 378:1031-1039. http://dx.doi.org/10.1016/j.jmb.2008.03.028.
51. Muller EE, Fayemiwo SA, Lewis DA. 2011. Characterization of a novel beta-lactamase-producing plasmid in Neisseria gonorrhoeae: sequence analysis and molecular typing ofhost gonococci. JAntimicrob Chemother 66:1514-1517. http://dx.doi.org/10.1093/jac/dkr162.
52. Vincent LR, Unemo M, Duncan M, Nicholas RA, Jerse AE. 2013. Fitness studies on Neisseria gonorrhoeae harboring mosaic penA alleles from ceftriaxone-resistant isolates predict the spread of resistance to extendedspectrum cephalosporins. Sex Transm Infect 89(Suppl 1):A67. http://dx.doi.org/10.1136/sextrans-2013-051184.0205.
53. Shimuta K, Unemo M, Nakayama SI, Morita-Ishihara T, Dorin M, Kawahata T, Ohnishi M, Antibiotic-Resistant Gonorrhea Study Group. 2013. Antimicrobial resistance and molecular typing of Neisseria gonorrhoeae isolates in Kyoto and Osaka, Japan, 2010 to 2012: intensified surveillance after identification of the first strain (H041) with high-level ceftriaxone resistance. Antimicrob Agents Chemother 57:5225-5232. http://dx.doi.org/10.1128/AAC.01295-13.
54. Gong ZJ, Lai W, Huang CW, Huang YQ, Xie XY. 2009. Multidrug resistance in two ceftriaxone-resistant Neisseria gonorrhoeae induced in vitro. Chin J Dermatol Venereol 23:68-70.